Clinical Trial Update: Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

View source ↗

Summary

A completed clinical trial evaluating the effectiveness and safety of adalimumab with high-dose methotrexate in routine clinical practice for rheumatoid arthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Methotrexate (high-dose) (Methotrexate)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-07-02